The European Center of Pharmaceutical Medicine (ECPM) designs and organizes the Master of Advanced Studies in Medicines Development program, together with partnering universities throughout Europe and other health care partner organizations. The program emphasizes integrated drug development, which is science-based, innovative, efficient and of high quality – leading to better and safer medical products for patients.
It is targeted at representatives from the pharmaceutical industry, service industry, academic and government decision- and policymakers who already have a good understanding of the basics of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product and device development, regulation and market introduction.
The program is structured in modules, which allows it to be completed next to working full- or part-time. Students can enroll in both the ECPM course and the master program.
In total, the Master of Advanced Studies requires a minimum of 60 ECTS.
30 ECTS (6 modules, triple exam) will be accredited by successfully completing the two-year ECPM Diploma Course - a well-established postgraduate education and training program - and acquiring the Diploma of Advanced Studies (DAS).
20 ECTS will be accredited for completing the master modules selected from the Continuing Professional Development (CPD) short courses list. These can be chosen by preference either from the ECPM CPD short course program, from other course providers or partner universities which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus.
The remaining 10 ECTS will be accredited for writing and submitting a master thesis.
|Disease Biology-Based Pharmacology||Core||3.0 ECTS||No|
|Translational Science and Pharmacology||Core||2.0 ECTS||No|
|Drug Safety and Pharmacovigilance: E-Learning||Core||1.0 ECTS|
|Essentials of Clinical Study Management||Core||1.0 ECTS||No|
|Basics in Health Economics: E-Learning||Core||Full Time||1.0 ECTS|
|Ethics and Regulation in Clinical Research||Elective||1.0 ECTS||No|
|Life Sciences Leadership and Business Strategies||Core||3.0 ECTS||No|
|Frontiers in Drug Development||Elective||Full Time||1.0 ECTS|
|Opening and Closing Presentations with POWER||No|
|Scientific Medical Writing||Elective||1.0 ECTS|